The LATAM Media Report
SEE OTHER BRANDS

Your media and advertising news from Latin America

The LATAM Media Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The LATAM Media Report.

Press releases published on May 27, 2025

GCM Grosvenor to Present at the Morgan Stanley 2025 U.S. Financials, Payments & CRE Conference on June 10, 2025

GCM Grosvenor to Present at the Morgan Stanley 2025 U.S. Financials, Payments & CRE Conference on June 10, 2025

CHICAGO, May 27, 2025 (GLOBE NEWSWIRE) -- GCM Grosvenor (Nasdaq: GCMG), a global alternative asset management solutions provider, announced today that Jon Levin, President of GCM Grosvenor, will present at the Morgan Stanley 2025 U.S. Financials, Payments …

InterDigital to Present at William Blair 45th Annual Growth Stock Conference

InterDigital to Present at William Blair 45th Annual Growth Stock Conference

WILMINGTON, Del., May 27, 2025 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a mobile, video and AI technology research and development company, today announced that the company will be presenting at the William Blair 45th Annual Growth Stock …

Digital Ally, Inc. Sets Date to Discuss First Quarter 2025 Earnings Call Wednesday, May 28, 2025 at 11:15 a.m. Eastern Time

Digital Ally, Inc. Sets Date to Discuss First Quarter 2025 Earnings Call Wednesday, May 28, 2025 at 11:15 a.m. Eastern Time

Overland Park, KS, May 27, 2025 (GLOBE NEWSWIRE) -- Digital Ally, Inc. (NASDAQ: DGLY) (the “Company”), today announced that it will host an investor conference call on Wednesday, May 28, 2025, at 11:15 a.m. Eastern time to discuss its operating results for …

Palisade Bio Reports Positive Phase 1a Results for PALI-2108, a First-in-Class Terminal Ileum and Colon-Targeted PDE4 B/D Inhibitor for Fibrostenotic Crohn’s Disease and Ulcerative Colitis

Palisade Bio Reports Positive Phase 1a Results for PALI-2108, a First-in-Class Terminal Ileum and Colon-Targeted PDE4 B/D Inhibitor for Fibrostenotic Crohn’s Disease and Ulcerative Colitis

Study met its primary endpoints of safety, tolerability, and pharmacokinetics (PK)  No serious adverse events (SAEs) or treatment-emergent adverse events (TEAEs) related to laboratory values or EKGs observed across SAD/MAD cohorts Management releases a “ …

Indonesia Energy Provides Update on Operations and Reserves and Planned Drilling During the Remainder of 2025

Indonesia Energy Provides Update on Operations and Reserves and Planned Drilling During the Remainder of 2025

2024 investments in seismic and other work and Kruh contract extension increased reserves at Kruh Block by over 60% JAKARTA, INDONESIA AND DANVILLE, CA, May 27, 2025 (GLOBE NEWSWIRE) -- Indonesia Energy Corporation (NYSE American: INDO) ("IEC"), an oil and …

NANO Nuclear Energy Announces Pricing of $105 Million Private Placement of Common Stock

NANO Nuclear Energy Announces Pricing of $105 Million Private Placement of Common Stock

The offering includes primary participation from fundamental institutional investors, including a leading long-only mutual fund and a preeminent global investment manager Company total cash position expected to be over $200 million following closing New …

Vemanti Group Announces Executive Leadership Appointment

Vemanti Group Announces Executive Leadership Appointment

Irvine, CA, May 27, 2025 (GLOBE NEWSWIRE) -- Vemanti Group, Inc. ("Vemanti" or the "Company") (OTCPK: VMNT) today announced the appointment of Matthew White as Chief Executive Officer of its subsidiaries, XPLOR Technology Pte. Ltd. ("XPLOR") and ONUS …

Inspira Technologies Aligns Executive Team Amid Corporate Structuring Initiatives

Inspira Technologies Aligns Executive Team Amid Corporate Structuring Initiatives

RA'ANANA, Israel, May 27, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) (“Inspira” or the “Company”), a pioneering company in advanced respiratory support and diagnostic systems, today announced an evolution in its executive …

GCL Subsidiary’s Offer for Ban Leong Technologies Declared Unconditional in all Respects

GCL Subsidiary’s Offer for Ban Leong Technologies Declared Unconditional in all Respects

SINGAPORE, May 27, 2025 (GLOBE NEWSWIRE) -- GCL Global Holdings Ltd. (NASDAQ: GCL) (“GCL” or the “Company”) is a leading provider of games and entertainment and the indirect parent company of Epicsoft Asia Pte. Ltd. (the “Offeror”), the bidder seeking to …

TopFX Celebrates 15 Years of Growth in Trading and Liquidity Services

TopFX Celebrates 15 Years of Growth in Trading and Liquidity Services

Mahé, Seychelles, May 27, 2025 (GLOBE NEWSWIRE) -- TopFX is proud to mark its 15th anniversary, celebrating a significant milestone in its journey of providing world-class forex trading solutions, deep liquidity access, and innovative trading technology to …

BioNTech präsentiert auf der ASCO-Jahrestagung 2025 Fortschritte aus der diversifizierten Onkologie-Pipeline

BioNTech präsentiert auf der ASCO-Jahrestagung 2025 Fortschritte aus der diversifizierten Onkologie-Pipeline

MAINZ, Deutschland, 27. Mai 2025 -- BioNTech SE (Nasdaq: BNTX, „BioNTech“ oder „das Unternehmen“) wird auf der Jahrestagung der American Society of Clinical Oncology („ASCO“), die vom 30. Mai bis 3. Juni 2025 in Chicago, Illinois, stattfindet, klinische …

BioNTech to Present Progress Across Diversified Oncology Pipeline at the 2025 ASCO Annual Meeting

BioNTech to Present Progress Across Diversified Oncology Pipeline at the 2025 ASCO Annual Meeting

MAINZ, Germany, May 27, 2025 -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present clinical trial data from select pipeline candidates across the Company’s diversified oncology portfolio at the American Society of Clinical Oncology (“ASCO …

Ocean Power Technologies Earns “Trusted Operator” Status in New AUVSI Maritime Certification Program

Ocean Power Technologies Earns “Trusted Operator” Status in New AUVSI Maritime Certification Program

MONROE TOWNSHIP, N.J., May 27, 2025 (GLOBE NEWSWIRE) -- Ocean Power Technologies, Inc. (NYSE American: OPTT) (“OPT” or the “Company”), a leader in innovative, cost-effective, low-carbon and artificial intelligence maritime services that enable safer and …

FLUENT Corp. to Report First Quarter 2025 Financial Results on May 29, 2025

FLUENT Corp. to Report First Quarter 2025 Financial Results on May 29, 2025

TAMPA, Fla., May 27, 2025 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) ("FLUENT" or the "Company"), a national cannabis consumer packaged goods company and retailer, today announced it will report financial results for the first quarter …

Breaking News: Rasool Rezvani (RZ) Named Among the Most Influential Crypto Figures of 2025

Breaking News: Rasool Rezvani (RZ) Named Among the Most Influential Crypto Figures of 2025

Dubai, UAE, May 27, 2025 (GLOBE NEWSWIRE) -- In a major recognition of global impact and innovation, Rasool Rezvani—widely known as RZ—has been officially named one of the Top Crypto Entrepreneurs of 2025, according to a recent report by International …

Candel Therapeutics to Host Investor Conference Call Featuring Expert Clinical Perspectives on CAN-2409 Phase 3 Prostate Cancer Data Following 2025 ASCO Presentation

Candel Therapeutics to Host Investor Conference Call Featuring Expert Clinical Perspectives on CAN-2409 Phase 3 Prostate Cancer Data Following 2025 ASCO Presentation

NEEDHAM, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today …

IMUNON Invited to Present Translational Data in Supporting Remarkable Phase 2 Ovarian Cancer Survival Results at ESMO Gynaecological Cancers Congress 2025

IMUNON Invited to Present Translational Data in Supporting Remarkable Phase 2 Ovarian Cancer Survival Results at ESMO Gynaecological Cancers Congress 2025

Presentation at ESMO will follow oral 2025 ASCO Annual Meeting presentation highlighting unprecedented survival data from Phase 2 OVATION 2 Study of IMNN-001 Simultaneously publication in leading peer-reviewed journal Gynecologic Oncology details IMNN-001’ …

StepStone Group to Present at the Morgan Stanley US Financials Conference

StepStone Group to Present at the Morgan Stanley US Financials Conference

NEW YORK, May 27, 2025 (GLOBE NEWSWIRE) -- StepStone Group Inc. (Nasdaq: STEP) today announced that Scott Hart, CEO, and Mike McCabe, Head of Strategy, are scheduled to present at the Morgan Stanley US Financials Conference on Tuesday, June 10, 2025, at 2: …

ARS Pharmaceuticals to Participate in Upcoming Investor Conferences

ARS Pharmaceuticals to Participate in Upcoming Investor Conferences

SAN DIEGO, May 27, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect themselves from allergic reactions that could lead to …

Camposol Holding PLC reports Preliminary First Quarter 2025 Results.

Camposol Holding PLC reports Preliminary First Quarter 2025 Results.

LIMA, Peru, May 26, 2025 -- Camposol Holding PLC (Camposol or the Company), a multinational company dedicated to providing fresh and healthy food globally, today announced its preliminary financial results for first quarter ended March 31, 2025. These …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service